Cempra

About:

Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.

Top Investors: Ontario Teachers' Pension Plan, Intersouth Partners, Aisling Capital, Quaker BioVentures, Devon Park BioVentures

Description:

Cempra seeks to discover and develop well-differentiated medicines that cure bacterial infections and improve the quality of life for those with chronic illnesses. The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future products from new technologies to derive the next generation of antibiotics.

Total Funding Amount:

$108M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Chapel Hill, North Carolina, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)cempra.com

Founders:

Prabhavathi Fernandes

Number of Employees:

51-100

Last Funding Date:

2012-10-30

IPO Status:

Delisted

Industries: